MENU
PBYI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Puma Biotechnology (PBYI) Earnings Date & Reports

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

PBYI is expected to report earnings to rise 3.33% to 15 cents per share on October 30

Puma Biotechnology PBYI Stock Earnings Reports
Q3'25
Est.
$0.16
Q2'25
Beat
by $0.06
Q4'24
Beat
by $0.32
Q3'24
Beat
by $0.13
Q2'24
Est.
$-0.05
The last earnings report on August 07 showed earnings per share of 15 cents, beating the estimate of 9 cents. With 504.78K shares outstanding, the current market capitalization sits at 163.31M.
View a ticker or compare two or three
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PBYI showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10880 Wilshire Boulevard
Phone
+1 424 248-6500
Employees
185
Web
http://www.pumabiotechnology.com